NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 918.50 DKK | +0.47% |
|
+4.20% | +31.57% |
| Sep. 13 | Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production | RE |
| Sep. 12 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | ZD |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 26 | |||||||||
| 25 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 26 | |||||||||
| 19 | |||||||||
| 20 | |||||||||
| 20 | |||||||||
| 24 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 21 | |||||||||
| 21 | |||||||||
| 15 | |||||||||
| 16 | |||||||||
| 17 | |||||||||
| 18 | |||||||||
| 15 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector revisions